Emergent BioSolutions Inc. EBS
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2006-11-15
Emergent BioSolutions Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 3,839,375 | $26.2M |
| D. E. Shaw & Co., Inc. | 1,003,912 | $8.3M |
| AQR CAPITAL MANAGEMENT LLC | 989,677 | $8.2M |
| RENAISSANCE TECHNOLOGIES LLC | 656,047 | $5.4M |
| TWO SIGMA INVESTMENTS, LP | 577,128 | $4.8M |
| MILLENNIUM MANAGEMENT LLC | 532,001 | $4.4M |
| CITADEL ADVISORS LLC | 128,200 | $1.1M |
Source: SEC EDGAR filings · CIK 0001367644 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.